TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the findings of new research by the Tufts Center for the Study of Drug Development ...
Critical Path Institute’s® Translational Therapeutics Accelerator today officially launched its 2026 global Request for Proposals for Bridging Research and Innovation in Drug Development Grants. These ...
The new venture is backed by Biovance Capital, Torrey Pines Investment, and OrbiMed. Mondego Bio is advancing a portfolio of first- and best-in-class PTPN2 inhibitors designed to transform cancer ...
The inflation-adjusted cost of developing a new drug now doubles roughly every nine years. To reverse this trend, the ...
Hackensack Meridian Health and Rutgers University have landed a multi-million-dollar grant from the National Institutes of Health to fast-track potential new drugs for antibiotic-resistant infections, ...
Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in biopharmaceutical manufacturing at every stage of ...
Hackensack Meridian Health and Johns Hopkins University are launching a consortium with big pharma to expedite the development of treatments for drug-resistant fungal infections. The group received a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results